Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:04 PM ET 8-K
Capital Raise Apollo Infrastructure Co LLC

Apollo Infrastructure Co Capital Raise of $39.5M

Apollo Infrastructure Company LLC issued and sold unregistered shares across multiple series to third-party investors for approximately $39.5 million in cash. The company also updated its Transactional Net Asset Value (NAV) per share as of September 30, 2026, and announced its intention to conduct quarterly share repurchases for up to 5.0% of its aggregate NAV.

Value
$39.5M
5:01 PM ET 8-K
M&A Deal DataMeds AI, Inc. MEDS

DataMeds AI M&A Deal with EOS Technology Holdings, Inc.

DataMEDS AI entered into a second amended and restated non-binding letter of intent to acquire intellectual property assets from EOS and Scilex Holding Company, and a controlling interest in Tollo Health (d/b/a Health Lives Here). The transaction involves an exchange of membership interests and the issuance of common stock that will result in the counterparties owning approximately 89.5% of the company's common stock on a fully diluted basis.

Counterparty
EOS Technology Holdings, Inc.
5:00 PM ET 8-K
Nasdaq/NYSE Compliance Notice YHN Acquisition I Ltd YHNAF

YHN Acquisition I Nasdaq/NYSE Compliance Notice

YHN Acquisition I Limited received a Staff Determination notice from Nasdaq on October 21, 2026, stating that the company failed to regain compliance with minimum market value requirements for continued listing. The company's board has decided not to appeal the delisting or transfer to the Nasdaq Capital Market, and trading is expected to be suspended on October 30, 2026. The company intends to apply for quotation on the OTC Markets following the delisting.

Counterparty
The Nasdaq Stock Market LLC
4:57 PM ET 8-K
Nasdaq/NYSE Compliance Notice Zeo Energy Corp. ZEO

Zeo Energy Nasdaq/NYSE Compliance Notice

Zeo Energy Corp. received a 180-day extension from Nasdaq, until April 19, 2027, to regain compliance with the $1.00 minimum bid price requirement. The company's Class A common stock will continue to trade on the Nasdaq Capital Market during this period while management monitors the stock price and considers options to meet the listing standard.

Counterparty
Nasdaq
Term
180 days
4:55 PM ET 8-K
Capital Raise Lycia Therapeutics, Inc. LYCA

Lycia Therapeutics Capital Raise

Lycia Therapeutics, Inc. filed its Amended and Restated Certificate of Incorporation and Bylaws in connection with the closing of its initial public offering. These governance changes were previously approved by the board and stockholders to take effect upon the IPO's completion.

4:53 PM ET 8-K
M&A Deal Rallybio Corp RLYB

Rallybio Signs $82.7M M&A Deal with Avenzo Therapeutics, Inc.

Rallybio Corporation provided a status update on its pending merger with Avenzo Therapeutics, declaring a special cash distribution of approximately $82.7 million ($13.56 per share) to stockholders. The distribution is based on the company's estimated net cash exceeding zero prior to the merger closing and is scheduled for payment on November 13, 2026.

Value
$82.7M
Counterparty
Avenzo Therapeutics, Inc.
4:53 PM ET 8-K
Capital Raise Apollo Asset Backed Credit Co LLC

Apollo Asset Backed Credit Co Capital Raise of $34.7M

Apollo Asset Backed Credit Company LLC issued and sold unregistered shares across multiple classes for total aggregate consideration of approximately $34.73 million as of October 1, 2026. The company also disclosed its Transactional Net Asset Value (NAV) per share as of September 30, 2026, which serves as the pricing basis for ongoing sales and its quarterly share repurchase program.

Value
$34.7M
4:47 PM ET 8-K
Clinical Trial Data Mirum Pharmaceuticals, Inc. MIRM

Mirum Pharmaceuticals Clinical Trial Data

Mirum Pharmaceuticals announced positive results from Cohort 2 of its pivotal PROGRESS study evaluating ATEBRIOZ (zilurgisertib) in pediatric patients aged 6 to <12 with fibrodysplasia ossificans progressiva (FOP). The study met its endpoints with a significant reduction in total heterotopic ossification lesion volume and improved joint mobility compared to placebo, supporting a planned sNDA submission in the first half of 2027.

4:45 PM ET 8-K
Clinical Trial Data Longeveron Inc. LGVN

Longeveron Clinical Trial Data

Longeveron announced updated Phase 2b ELPIS II trial results for laromestrocel in infants with hypoplastic left heart syndrome (HLHS). While the trial missed its primary efficacy endpoint of RVEF change, additional analysis showed the secondary endpoint of major adverse cardiac events (MACE) achieved statistical significance with only 1 event in the treatment arm versus 8 in the standard of care arm (P=0.043).

Counterparty
National Institutes of Health (NIH)
4:41 PM ET 8-K
Clinical Trial Data Cumberland Pharmaceuticals Inc CPIX

Cumberland Pharmaceuticals Clinical Trial Data

Cumberland Pharmaceuticals announced plans to submit a New Drug Application (NDA) for ifetroban to treat cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The submission is supported by Phase 2 FIGHT DMD trial data showing a statistically significant 5.4% improvement in left ventricular ejection fraction (LVEF) compared to a control group. While the FDA expressed concerns regarding the sufficiency of the data package for efficacy requirements, the company is moving forward with the submission following a pre-NDA meeting.

Counterparty
FDA
4:40 PM ET 8-K
M&A Deal Weave Communications, Inc. WEAV

Weave Communications Signs $650M M&A Deal with Francisco Partners

Weave Communications, Inc. completed its acquisition by Francisco Partners in an all-cash transaction valued at approximately $650 million. Under the terms of the deal, Weave stockholders received $7.40 per share, and the company has transitioned to a privately held entity, delisting from the New York Stock Exchange.

Value
$650M
Counterparty
Francisco Partners

“Today marks the start of an exciting new chapter for Weave. For nearly two decades, Weave has built solutions for independent practices caring for patients in communities across the country. Today, more than 40,000 locations rely on us to deepen their relationship with patients through automated communication and engagement solutions. With Francisco Partners’ support and resources, we’re well positioned to deliver even more value to the practices we serve. I want to thank our employees, whose dedication made this milestone possible.”

Brett White, Chief Executive Officer of Weave

“Weave sits at the center of how tens of thousands of healthcare practices communicate with their patients and collect revenue. We are pleased to officially partner with Brett and the Weave team and see significant opportunity to build on that position through continued product innovation in AI-powered patient engagement and payments solutions.”

Ezra Perlman, Co-President at Francisco Partners
4:36 PM ET 8-K
Capital Raise NewHydrogen, Inc. NEWH

NewHydrogen Capital Raise of $3M

NewHydrogen, Inc. entered into a securities purchase agreement with SunHydrogen, Inc. to raise approximately $3 million through the issuance of 203,650,000 shares of common stock and warrants to purchase an additional 407,300,000 shares. The common stock was priced at $0.01473 per share, and the proceeds are intended for general corporate purposes and working capital.

Value
$3M
Counterparty
SunHydrogen, Inc.
4:36 PM ET 8-K
M&A Deal North Haven Private Income Fund A LLC

North Haven Private Income Fund A M&A Deal with North Haven Private Income Fund LLC

North Haven Private Income Fund A LLC (PIF A) has entered into a definitive merger agreement to be acquired by North Haven Private Income Fund LLC (PIF). The transaction will be a NAV-for-NAV exchange where PIF A unitholders will receive Class I units of PIF, creating a combined entity with approximately $6.6 billion in total investments.

Counterparty
North Haven Private Income Fund LLC

“we are pleased with the Companies’ performance and believe the Merger will create value for investors, including through a reduced management fee. The Merger advances our long-standing strategic vision and better positions PIF to capitalize on the strength of the Morgan Stanley platform to scale further in the marketplace.”

Michael Occi, Chief Executive Officer of the Companies
4:35 PM ET 8-K
Capital Raise PennantPark Private Income Fund

PennantPark Private Income Fund Capital Raise of $3.08M

PennantPark Private Income Fund issued and sold 118,703 common shares for aggregate proceeds of approximately $3.08 million on October 1, 2026. The sale was conducted as part of the company's ongoing continuous private offering to accredited investors. Additionally, the company reported a net asset value (NAV) per share of $25.95 as of September 30, 2026.

Value
$3.08M
4:34 PM ET 8-K
Partnership Applied Materials Inc AMAT

Applied Materials Partnership with BE Semiconductor Industries N.V.

Applied Materials entered into an accelerated share purchase agreement to increase its minority stake in BE Semiconductor Industries (Besi) to approximately 20%. The investment reinforces a long-term strategic partnership focused on co-innovating advanced packaging and hybrid bonding technologies for AI-driven semiconductor scaling.

Counterparty
BE Semiconductor Industries N.V.
4:33 PM ET 8-K
M&A Deal North Haven Private Income Fund LLC

North Haven Private Income Fund M&A Deal with North Haven Private Income Fund A LLC

North Haven Private Income Fund LLC (PIF) has entered into a definitive agreement to acquire North Haven Private Income Fund A LLC (PIF A) in a NAV-for-NAV exchange ratio merger. The combined entity is expected to have approximately $6.6 billion in total investments at fair value and will benefit from a reduced management fee of 1.00%. The transaction is expected to close in December 2026, subject to regulatory approvals and customary closing conditions.

Counterparty
North Haven Private Income Fund A LLC

“we are pleased with the Companies’ performance and believe the Merger will create value for investors, including through a reduced management fee. The Merger advances our long-standing strategic vision and better positions PIF to capitalize on the strength of the Morgan Stanley platform to scale further in the marketplace.”

Michael Occi, Chief Executive Officer of the Companies
4:17 PM ET 8-K
Divestiture Senti Biosciences Holdings, Inc. SNTI

Senti Biosciences Holdings Divestiture to ST NewCo Limited for $60M

Senti Biosciences completed the divestiture of its entire ownership interest in its operating subsidiaries, Midco and Opco, to ST NewCo Limited. In exchange, Senti shareholders will receive contingent value rights (CVRs) entitling them to up to $60.0 million in milestone payments tied to the FDA approval and commercial success of the CAR-NK cell therapy SENTI-202.

Value
$60M
Counterparty
ST NewCo Limited
Term
7 years
4:17 PM ET 8-K
Capital Raise KKR Infrastructure Conglomerate LLC

KKR Infrastructure Conglomerate Capital Raise of $243M

KKR Infrastructure Conglomerate LLC sold approximately $242.9 million in unregistered Class I-Series 1, Class S, and Class D shares to investors for cash on October 1, 2026. This sale is part of a continuous private offering that has raised approximately $8,222 million since its inception in June 2023.

Value
$243M
4:17 PM ET 8-K
Capital Raise Rent the Runway, Inc. RENT

Rent the Runway Capital Raise of $15M

Rent the Runway completed a $15 million rights offering, raising approximately $8.9 million from subscribers and $6.1 million from a backstop commitment. An investor group consisting of CHS US Investments LLC, Gateway Runway, LLC, and S3 RR Aggregator, LLC purchased the remaining 1,724,089 unsubscribed shares at $3.55 per share.

Value
$15M
Counterparty
CHS US Investments LLC
4:16 PM ET 8-K
Nasdaq/NYSE Compliance Notice Azio AI Holdings, Inc. AZIO

Azio AI Holdings Nasdaq/NYSE Compliance Notice

Azio AI Holdings announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. The company achieved this through a business combination with Azio AI Corporation, warrant exercises, and share issuances under a standby equity purchase agreement. Nasdaq will continue to monitor the company's compliance through its next periodic financial report.

Counterparty
The Nasdaq Stock Market LLC
4:12 PM ET 8-K
M&A Deal RadNet, Inc. RDNT

RadNet Signs $350M M&A Deal with OnRad, Inc.

RadNet has entered into a definitive agreement to acquire OnRad, Inc., a provider of teleradiology and in-hospital professional radiology staffing services, for $350 million in cash and 5 million shares of RadNet common stock. The deal includes a potential earn-out of up to $210 million based on 2027 EBITDA targets and will establish a new 'Radiology Professional Services' operating segment for RadNet. The acquisition is expected to close in early 2027 and add approximately $190 million to $200 million in annual revenue.

Value
$350M
Counterparty
OnRad, Inc.

“This is the next step in building an imaging company with comprehensive solutions that brings technology, radiology professional services and imaging operations together to address some of healthcare’s most pressing challenges and needs.”

Dr. Howard Berger, President and CEO of RadNet

“I welcome ONRAD’s executive team, its contracted radiologists and all other ONRAD team members into the RadNet family. This transaction is a significant additional step in leading our industry forward and demonstrating the impact that a transformation to workflow solutions in diagnostic imaging can have in advancing early detection, population health and improved patient outcomes.”

Dr. Howard Berger, President and CEO of RadNet
4:11 PM ET 8-K
Capital Raise KKR Private Equity Conglomerate LLC

KKR Private Equity Conglomerate Capital Raise of $290M

KKR Private Equity Conglomerate LLC sold approximately $289.5 million in unregistered shares across multiple classes (Class I, U, S, and D) to investors for cash on October 1, 2026. This transaction is part of a continuous private offering that has raised approximately $11.17 billion for the company since its inception in August 2023.

Value
$290M
4:06 PM ET 8-K
Capital Raise BranchOut Food Inc. BOF

BranchOut Food Capital Raise of $5M

BranchOut Food Inc. priced an underwritten public offering of 2,941,177 shares of common stock at $1.70 per share, raising approximately $5.0 million in gross proceeds. The company intends to use the net proceeds for working capital, general corporate purposes, and capital expenditures.

Value
$5M
Counterparty
Lake Street Capital Markets LLC
12:51 PM ET 8-K
M&A Deal Ufp Industries Inc UFPI

Ufp Industries Signs $27M M&A Deal with Apache Products, Inc.

UFP Industries has entered into a definitive agreement to acquire the operating assets of Apache Products, Inc. (dba Acme Skid), a Texas-based pallet manufacturer, for approximately $27 million. The acquisition adds approximately $55 million in annual sales and expands UFP Packaging's manufacturing footprint in the Gulf Coast industrial and petrochemical market.

Value
$27M
Counterparty
Apache Products, Inc.

“Apache is the kind of business we look for at UFP: an established market leader with long-standing customer relationships, a disciplined operation and an experienced team that has a proven track record of execution. This acquisition tracks with our other investments this year—broadening our reach into a strategically important geography and creating opportunities to grow with our national customers across the region to create long-term value.”

Will Schwartz, chief executive officer of UFP Industries

“The Gulf Coast is one of the country's most important industrial packaging markets, driven by concentrated manufacturing, energy and petrochemical activity. The team at Apache will expand our ability to support customers as they grow through greater efficiency, scale and access to a larger range of packaging solutions.”

Scott Worthington, president of UFP Packaging
11:32 AM ET 8-K
Capital Raise Sound Point Direct Lending BDC

Sound Point Direct Lending BDC Capital Raise of $41.1M

Sound Point Direct Lending BDC issued approximately 1.64 million common shares to investors for aggregate proceeds of approximately $41.1 million. The sale was conducted via a capital drawdown notice under existing subscription agreements and closed on October 22, 2026.

Value
$41.1M
11:31 AM ET 8-K
Divestiture Faraday Future Intelligent Electric Inc. FFAI

Faraday Future Intelligent Electric Divestiture to FF EAI Robotics Ecosystem Inc. for $200M

Faraday Future completed the sale of its Robotics Business to FF EAI Robotics Ecosystem Inc. (FFR) for an aggregate consideration of $200 million. The transaction establishes FFR as an independent Nasdaq-listed robotics platform while Faraday Future pivots toward Robotaxi and shared mobility operations.

Value
$200M
Counterparty
FF EAI Robotics Ecosystem Inc.

“This transaction represents a transformative milestone for both companies and reinforces our long-term vision to become a leader in the Embodied AI era. Combining RoboShare’s capabilities with a dedicated public-company platform for robotics positions us to accelerate technology development, AI innovation, and commercial growth while expanding the adoption of intelligent robotic solutions across everyday commercial and industrial use cases.”

YT Jia, Founder and Global Chief Executive Officer of Faraday Future
11:31 AM ET 8-K
M&A Deal FF EAI Robotics Ecosystem Inc. FFR

FF EAI Robotics Ecosystem M&A Deal with Faraday Future Intelligent Electric Inc.

FF EAI Robotics Ecosystem Inc. completed its acquisition of the robotics business of Faraday Future Intelligent Electric Inc. (FFAI) on October 23, 2026. The transaction involved the merger of FF EAI Robotics Inc. into a subsidiary of the company and included exclusive technology licensing and intellectual property assignments to establish a standalone Nasdaq-listed robotics platform.

Counterparty
Faraday Future Intelligent Electric Inc.

“The completion of this transaction marks an important milestone in establishing a dedicated public company focused on Embodied AI robotics. We believe this platform provides a strong foundation to accelerate commercialization and expand the adoption of intelligent robotics across real-world applications.”

YT Jia, Chief Executive Officer of FFR

“FFR’s focus is on building a scalable robotics business that brings Physical AI robotic technologies into everyday commercial and industrial applications. We look forward to expanding our products, services and capabilities as we enter into this next stage of growth.”

YT Jia, Chief Executive Officer of FFR
9:07 AM ET 8-K
M&A Deal GigCapital9 Corp. GIX

GigCapital9 Announces $600M M&A Deal

GigCapital9 Corp. has entered into a non-binding letter of intent for a business combination with a leading clean energy technology company specializing in post-combustion carbon capture. The proposed transaction sets a pre-money enterprise value for the target company of approximately $600 million, plus a potential $100 million earnout. The deal aims to support the commercialization of clean firm power applications required for AI-driven power demand growth.

Value
$600M
9:05 AM ET 8-K
Capital Raise Peraso Inc. PRSO

Peraso Capital Raise of $10M

Peraso Inc. entered into a definitive agreement for a $10 million strategic private placement with Nant Capital, LLC. The offering includes common stock, pre-funded warrants, and accompanying common stock purchase warrants to accelerate the development and commercialization of 60 GHz mmWave technology for drone communications.

Value
$10M
Counterparty
Nant Capital, LLC
9:04 AM ET 8-K
M&A Deal Surgery Partners, Inc. SGRY

Surgery Partners Signs $5.7B M&A Deal with HealthSpan Partners

Surgery Partners, Inc. has entered into a definitive agreement to be acquired by HealthSpan Partners, an affiliate of Bon Secours Mercy Health, in an all-cash transaction with an enterprise value of approximately $5.7 billion. Shareholders will receive $23.50 per share in cash, while Bain Capital will roll over its existing equity to remain a significant partner in the combined outpatient surgical care platform.

Value
$5.7B
Counterparty
HealthSpan Partners

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.